Page last updated: 2024-10-21

hydroxyindoleacetic acid and Marfan Syndrome

hydroxyindoleacetic acid has been researched along with Marfan Syndrome in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stoerner, JW1
Butler, IJ1
Morriss, FH1
Howell, RR1
Seifert, WE1
Caprioli, RM1
Adcock, EW1
Denson, SE1

Other Studies

1 other study available for hydroxyindoleacetic acid and Marfan Syndrome

ArticleYear
CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia.
    American journal of diseases of children (1960), 1980, Volume: 134, Issue:5

    Topics: Ascorbic Acid; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, Newborn

1980